Patient info Open main menu

Difflam eucalyptus flavour 3 mg Lozenges – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

Medicine strength:
3 mg
Contains active substance:

Patient leaflet - Difflam Eucalyptus Flavour 3 mg lozenges

1. What Difflam Lozenges is and what it is used for

Difflam contains the active substance benzydamine hydrochloride, which is a local anti-inflammatory agent.

Difflam is used in adults and children above 6 years of age for symptomatic local treatment for the relief of pain and irritation of the mouth and throat.

You must talk to a doctor if you do not feel better or if you feel worse after 3 days.

2. What you need to know before you take Difflam Lozenges

Do not take Difflam Lozenges:

  • If you are allergic to benzydamine or any of the other ingredients of this medicine (listed in section 6).
  • If you suffer from a condition known as phenylketonuria
  • If you are allergic to aspirin (also called as salicylic acid) or to other anti-inflammatory painkillers called NSAIDs (e.g. ibuprofen).

Warnings and precautions

Talk to your doctor or pharmacist before taking this medicine:

  • If you have a history of Asthma.
  • If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
  • If after using the lozenges the pain in your mouth or throat gets worse or does not improve within 3 days or you appear feverish or have other symptoms, you should speak to your doctor or pharmacist.

Taking other medicines and Difflam Lozenges

Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription.

Difflam Lozenges are not expected to affect other medicines, however if you are not sure, please ask your doctor or pharmacist about other medicines obtained without a prescription.

Difflam Lozenges with food, drink

Food and drink have no influence.

Pregnancy, breast-feeding

If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby ask your doctor or pharmacist for advice before taking this medicine.

You should not use Difflam lozenges during pregnancy unless clearly necessary and advised by your doctor. If you need treatment the lowest dose for the shortest time possible should be used.

Difflam lozenges should not be used during breast-feeding.

Driving and using machines

Difflam Lozenges does not affect your ability to drive or use machines.

Difflam Lozenges contains

Isomalt (which is a type of sugar): If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

Eucalyptus oil with d-Limonene.

It may cause allergic reactions.

3. How to take Difflam Lozenges

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is:

Adults and children over 6 years old: one lozenge 3 times a day. Do not take more than 3 lozenges per day.

Use in children

Children from 6 to 11 years old: this medicinal product should be administered under an adult supervision.

Children under the age of 6 years old should not be given Difflam Lozenges.

Let one lozenge dissolve slowly in your mouth up to three times a day.

Do not swallow.

Do not chew.

Difflam should not be used for more than 7 days.

If after using the lozenges your throat gets worse or does not feel better, speak to your pharmacist or doctor.

If you take more Difflam Lozenges than you should

If you accidentally take too many lozenges, you should contact your pharmacist, doctor or nearest hospital casualty department immediately. Always take the labelled medicine package with you, whether there are any lozenges left or not.

4. Possible side effects

Like all medicines, this medicine can cause side-effects, although not everybody gets them.

Allergic reactions are rare but can be serious. Tell your doctor immediately if you get any sudden swelling in the mouth/ throat, difficulty breathing, rash or itching especially if affecting the whole body.

Uncommon (may affect up to 1 in 100 people):

  • Skin sensitivity to sunlight (causing a rash or sunburn).

Rare (may affect up to 1 in 1,000 people):

  • Burning sensation or dryness of the mouth. If this happens to you, try sipping a glass of water to reduce the effect.

Very rare (may affect up to 1 in every 10,000 people)

  • Sudden swelling in the mouth/throat and mucous membranes (angioedema).
  • Difficulty breathing (laryngospasm).

Not known (frequency cannot be estimated from the available data):

  • Local loss of sensitivity of the oral mucosa (hypoesthesia oral)
  • Allergic reaction (Hypersensitivity)
  • Serious allergic reaction (anaphylactic shock), signs of which may include difficulty breathing, chest pain or chest tightness, and/ or feeling dizzy/faint, severe itching of the skin or raised lumps on the skin, swelling of the face, lips, tongue and /or throat, and which may be potentially life-threatening.

Reporting of side effects

If you get any the side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (www.mhra.gov.uk/yellowcard or search for MHRA yellow card in the Google Play or Apple App Store). By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Difflam Lozenges

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date, which is stated on the label after EXP. The expiry date refers to the last day of that month.

Do not store above 30°C.

Store in the original package in order to protect from moisture.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Difflam Lozenges contains:

  • The active substance is benzydamine
  • Each lozenge contains 3 mg of benzydamine hydrochloride (equivalent to 2.68 mg benzydamine).
  • The other ingredients are isomalt (E 953), acesulfame potassium, citric acid monohydrate, eucalyptus oil (with d-Limonene), levomenthol, quinoline yellow (E 104), indigotine dye (E 132).

What Difflam Lozenges looks like and contents of the pack

Difflam Lozenges are dark-green, square shaped lozenges with a central cavity, wrapped in food paper. Difflam Lozenges are provided in packs containing 20 lozenges.

Marketing Authorisation Holder and Manufacturer

The Marketing Authorisation Holder

is

Cooper Consumer Health B.V.,

Verrijn Stuartweg 60, 1112 AX Diemen,

The Netherlands

The Manufacturers is:

A.C.R.A.F. S.p.A.,

Via Vecchia del Pinocchio,22

60131 – Ancona, Italy

This leaflet was last revised in April 2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 60682/0010

Last revision stated in the text: April 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Difflam Eucalyptus Flavour 3 mg lozenges

Active substance Benzydamine
Strength 3 mg
Pharmaceutical form Lozenge
Dark-green square-shaped lozenges, with a central cavity.
How is it taken Oromucosal
Excipients Isomalt (E 953),, Eucalyptus oil (with d-Limonene),, Citric acid, monohydrate,, Acesulfame potassium,, Levomenthol,, Quinoline yellow (E 104),, Indigotine (E132).
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 4 years
Storage Do not store above 30°C.
Store in original package in order to protect from moisture.
Drug group (ATC) Other throat preparations
  1. R Respiratory system drugs
    1. R02 Throat preparations
      1. R02A Throat preparations
        1. R02AX Other throat preparations
          1. R02AX03 benzydamine
Marketing authorisation PL 60682/0010 (first authorised 30 May 2013)
Marketing authorisation holder Cooper Consumer Health B.V.
Codes BNF 12030300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.